Eric B. Lev | Ampersand Capital

Eric B. Lev

Eric B. Lev

General Partner


Eric, who joined Ampersand in 2013, has 18 years of middle market healthcare investment experience. Eric’s current and past board seats include ALPCO, Biologos, Biosynth, CutisPharma, Genoptix, iuvo Biosciences, LakePharma, Leinco Technologies, Nexelis, Nexcelom Biosciences, P95 and Resolian (formerly Alliance Pharma). Before joining Ampersand, he spent seven years as a member of the investment team at Water Street Healthcare Partners. Prior to Water Street, Eric worked at Beckman Coulter and One Equity Partners. Eric holds a B.A. in Economics from Northwestern University and a M.B.A. from the University of Chicago.